Device Trial Radar · NCT00166205
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Last checked: Nov 20, 2026Latest source record: Sep 1, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
276
Actual
Start
Jun 2003
Primary completion
Not stated
Study completion Dec 2006
Sponsor
- Lead sponsor
- Ethicon Endo-SurgeryPublic (JNJ)
- Sponsor type
- Industry
- First posted
- Sep 14, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether the Swedish Adjustable Gastric Band (SAGB) is safe, and effective in achieving weight loss in patients with Morbid Obesity.
Conditions
- Obesity, Morbid
Interventions
Swedish Adjustable Gastric BandDevice
Long term implantable device.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent of Subjects Who Had Adverse Events With the Swedish Adjustable Gastric Band (SAGB)Time frame: 3 years
- Percent Excess Weight LossTime frame: 3 Years Post Operative
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Cedars-Sinai Medical Center
Los Angeles, California
Scripps Clinic Medical Group
San Diego, California
US Bariatrics
Fort Lauderdale, Florida
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.